Clinical Case of Diagnosis and Treatment of Skin Cancer from Sebaceous Glands
K. S. Titov,
Sh. R. Dzhamilov,
I. N. Lebedinsky,
P. M. Gur’eva,
M. V. Sorokina,
E. I. Zakurdaev,
D. N. Grekov https://doi.org/10.17650/2219-4614-2024-16-2-87-93
Abstract
Skin cancer from sebaceous glands is a rare and aggressive malignant tumor developing from skin appendages. The etiology of this tumor is still unclear and requires further investigation. Furthermore, strict guidelines on management of patients with this pathology have not been formulated. The article presents a clinical case of diagnosis and treatment of skin cancer from sebaceous glands.
About the Authors
K. S. Titov
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department ; Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
5 2nd Botkinskij Proezd, Moscow 125284
6 Miklukho-Maklaya St., Moscow, 117198
Sh. R. Dzhamilov
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department
Russian Federation
Russian Federation
5 2nd Botkinskij Proezd, Moscow 125284
I. N. Lebedinsky
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department
Russian Federation
Russian Federation
5 2nd Botkinskij Proezd, Moscow 125284
P. M. Gur’eva
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department
Russian Federation
Russian Federation
5 2nd Botkinskij Proezd, Moscow 125284
M. V. Sorokina
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department
Russian Federation
Russian Federation
5 2nd Botkinskij Proezd, Moscow 125284
E. I. Zakurdaev
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department
Russian Federation
Russian Federation
5 2nd Botkinskij Proezd, Moscow 125284
D. N. Grekov
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department ; Russian Medical Academy of Continuous Professional Education
Russian Federation
Russian Federation
5 2nd Botkinskij Proezd, Moscow 125284
Bld. 1, 2/1 Barrikadnaya St., Moscow 125993
References
1. Kazakov D.V., McKee P.H., Michal M., Kacerovska D. Cutaneous adnexal tumors. 1st edn. Philadelphia: Lippincott Williams and Wilkins Health, 2012.
2. Owen J.L., Kibbi N., Worley B. et al. Sebaceous carcinoma: evidence-based clinical practice guidelines. Lancet Oncol 2019;20(12):e699–714. DOI: 10.1016/S1470-2045(19)30673-4
3. Gall R., Ortiz-Perez S. Sebaceous gland carcinoma. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK562223/.
4. Ouyang Y.-H. Skin cancer of the head and neck. Semin Plastic Surg 2010;24(2):117–26. DOI: 10.1055/s-0030-1255329. ISSN 1535-2188
5. Knackstedt T., Samie F.H. Sebaceous carcinoma: a review of the scientific literature. Curr Treat Options Oncol 2017;18(8):47. DOI: 10.1007/s11864-017-0490-0
6. Ishida M., Iwai M., Yoshida K. et al. Sebaceous carcinoma associated with Bowen’s disease: a case report with emphasis on the pathogenesis of sebaceous carcinoma. Int J Clin Exp Pathol 2013;6(12):3029–32.
7. Wu A., Rajak S.N., Huilgol Sh.C. et al. Cutaneous sebaceous carcinoma. Australas J Dermatol 2020;61(3):e283–92. DOI: 10.1111/ajd.13234
8. Kyllo R.L., Brady K.L., Hurst E.A. Sebaceous carcinoma: review of the literature. Dermatol Surg 2015;41(1):1–15. DOI: 10.1097/DSS.0000000000000152
9. Flux K. Sebaceous Neoplasms. Surg Pathol Clin 2017;10(2):367–82. DOI: 10.1016/j.path.2017.01.009
10. Takeda H., Lyle S., Lazar A.J. et al. Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med 2006;12(4):395–7. DOI: 10.1038/nm1386
11. Gay J.T., Troxell T., Gross G.P. Muir-torre syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023.
12. Jessup C.J., Redston M., Tilton E., Reimann J.D. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir–Torre syndrome. Hum Pathol 2016;49:1–9. DOI: 10.1016/j.humpath.2015.10.005
13. Tetzlaff M.T., Singh R.R., Seviour E.G. et al. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol 2016;240(1):84–95. DOI: 10.1002/path.4759
14. Lee M.J., Kim N., Choung H.K. et al. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target. J Cancer Res Clin Oncol 2016;142(1):125–33. DOI: 10.1007/s00432-015-2009-z
15. Sargen M.R., Starrett G.J., Engels E.A. et al. Sebaceous carcinoma epidemiology and genetics: emerging concepts and clinical implications for screening, prevention, and treatment. Clin Cancer Res 2021;27(2):389–93. DOI: 10.1158/1078-0432.ccr-20-2473
16. Sekgololo J.M., Chauke R.F., Tshazi N. A rare giant extraocular, anterior chest wall sebaceous carcinoma. Int J Surg Case Rep 2020;66:110–4. DOI: 10.1016/j.ijscr.2019.11.054
17. Dermatooncology. Ed. by G.A. Galil-ogly, V.A. Molochkov, Yu.V. Sergeeva. Moscow, 2005. 443 p. (In Russ.).
18. Sebaceous tumors. Atlas of mohs and frozen section cutaneous pathology. Ed. by M.B. Morgan, J.R. Hamill, J.M. Spencer. NY: Springer, 2010. Pp. 133–140.
19. Roberts M.E., Riegert-Johnson D.L., Thomas B.C. et al. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir–Torre variant of Lynch syndrome. Genet Med 2014;16(9):711–6. DOI: 10.1038/gim.2014.19
20. John A.M., Schwartz R.A. Muir–Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol 2016;74(3):558–66. DOI: 10.1016/j.jaad.2015.09.074
21. Dany M. The DNA mismatch repair system in sebaceous tumors: an update on the genetics and workup of Muir-Torre syndrome. Cutis 2020;105(3):E34–7.
22. Dasgupta T., Wilson L.D., Yu J.B. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer 2009;115(1):158–65. DOI: 10.1002/cncr.23952
Review
For citations:
Titov K.S., Dzhamilov Sh.R., Lebedinsky I.N., Gur’eva P.M., Sorokina M.V., Zakurdaev E.I., Grekov D.N. Clinical Case of Diagnosis and Treatment of Skin Cancer from Sebaceous Glands. Bone and soft tissue sarcomas, tumors of the skin. 2024;16(2):87-93. (In Russ.) https://doi.org/10.17650/2219-4614-2024-16-2-87-93
Views:
542
Email this article 
